The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase IB/II study of neoadjuvant chemoradiotherapy with CRLX101 and capecitabine for locally advanced rectal cancer.
 
Andrew Wang
Stock and Other Ownership Interests - Biogen; Gilead Sciences; Shire
Patents, Royalties, Other Intellectual Property - Phenixsongs
 
Hanna Kelly Sanoff
Consulting or Advisory Role - Amgen
Research Funding - Bayer (Inst); Novartis (Inst)
 
Autumn Jackson McRee
No Relationships to Disclose
 
Bert H. O'Neil
Consulting or Advisory Role - Acceleron Pharma; Amgen; Genentech/Roche; Lilly/ImClone; Sanofi
Speakers' Bureau - Amgen
Research Funding - Novartis (Inst)
 
Benjamin F. Calvo
No Relationships to Disclose
 
Meliessa G. Hennessy
Employment - Cerulean Pharma
Stock and Other Ownership Interests - Cerulean Pharma
 
Curran Murphy
Employment - Takeda (I)
Stock and Other Ownership Interests - Takeda (I)
Research Funding - Takeda (I)
Travel, Accommodations, Expenses - Takeda (I)
 
Maureen T. Tynan
No Relationships to Disclose
 
A. William Blackstock
No Relationships to Disclose
 
Edward Graeme Garmey
Employment - Cerulean Pharma
Stock and Other Ownership Interests - Cerulean Pharma
 
Joel E. Tepper
Consulting or Advisory Role - Natera